Cipla strengthens respiratory care play with iCaltech stake acquisition

has completed its ₹5 crore investment to acquire a 20% stake in Bengaluru-based iCaltech Innovations, securing equal voting rights in the company through preference shares and one equity share. iCaltech, an ISO 13485-certified medical device maker, focuses on respiratory diagnostics and reported strong revenue growth of ₹6.7 crore in FY25, up from ₹4.19 crore in FY24 and ₹1.28 crore in FY23. The partnership allows Cipla to integrate its pharmaceutical strength with iCaltech’s device expertise, reinforcing its long-term strategy in building holistic respiratory care solutions while enabling the startup to operate independently and scale further. Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.